189 related articles for article (PubMed ID: 31398997)
1. Double-blind placebo-controlled randomized clinical trial of ginger (
Martins LB; Rodrigues AMDS; Monteze NM; Tibaes JRB; Amaral MHA; Gomez RS; Teixeira AL; Ferreira AVM
Cephalalgia; 2020 Jan; 40(1):88-95. PubMed ID: 31398997
[TBL] [Abstract][Full Text] [Related]
2. Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc.) addition in migraine acute treatment.
Martins LB; Rodrigues AMDS; Rodrigues DF; Dos Santos LC; Teixeira AL; Ferreira AVM
Cephalalgia; 2019 Jan; 39(1):68-76. PubMed ID: 29768938
[TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
5. Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).
Bayer O; Adrion C; Al Tawil A; Mansmann U; Strupp M;
Trials; 2019 Dec; 20(1):813. PubMed ID: 31888723
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
10. Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial.
Rahnama P; Montazeri A; Huseini HF; Kianbakht S; Naseri M
BMC Complement Altern Med; 2012 Jul; 12():92. PubMed ID: 22781186
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
[TBL] [Abstract][Full Text] [Related]
12. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
Dodick DW; Silberstein SD; Bigal ME; Yeung PP; Goadsby PJ; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y; Aycardi E
JAMA; 2018 May; 319(19):1999-2008. PubMed ID: 29800211
[TBL] [Abstract][Full Text] [Related]
13. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
[TBL] [Abstract][Full Text] [Related]
14. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
15. Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial.
Wilkinson D; Ade KK; Rogers LL; Attix DK; Kuchibhatla M; Slade MD; Smith LL; Poynter KP; Laskowitz DT; Freeman MC; Hoffer ME; Saper JR; Scott DL; Sakel M; Calhoun AH; Black RD
Headache; 2017 Jul; 57(7):1065-1087. PubMed ID: 28656612
[TBL] [Abstract][Full Text] [Related]
16. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
Dilli E; Halker R; Vargas B; Hentz J; Radam T; Rogers R; Dodick D
Cephalalgia; 2015 Oct; 35(11):959-68. PubMed ID: 25505035
[TBL] [Abstract][Full Text] [Related]
17. Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States.
Woolley JM; Bonafede MM; Maiese BA; Lenz RA
Headache; 2017 Oct; 57(9):1399-1408. PubMed ID: 28842990
[TBL] [Abstract][Full Text] [Related]
18. Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
Ferrari MD; Diener HC; Ning X; Galic M; Cohen JM; Yang R; Mueller M; Ahn AH; Schwartz YC; Grozinski-Wolff M; Janka L; Ashina M
Lancet; 2019 Sep; 394(10203):1030-1040. PubMed ID: 31427046
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine.
Maghbooli M; Golipour F; Moghimi Esfandabadi A; Yousefi M
Phytother Res; 2014 Mar; 28(3):412-5. PubMed ID: 23657930
[TBL] [Abstract][Full Text] [Related]
20. Ginger for Migraine.
Andrade C
J Clin Psychiatry; 2021 Nov; 82(6):. PubMed ID: 34851560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
